The spectrum of pediatric amplified musculoskeletal pain syndrome.


Journal

Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897

Informations de publication

Date de publication:
12 Oct 2020
Historique:
received: 22 05 2020
accepted: 06 10 2020
entrez: 13 10 2020
pubmed: 14 10 2020
medline: 3 8 2021
Statut: epublish

Résumé

Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia. We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale. We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001). There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population.

Sections du résumé

BACKGROUND BACKGROUND
Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia.
METHODS METHODS
We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale.
RESULTS RESULTS
We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001).
CONCLUSIONS CONCLUSIONS
There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population.

Identifiants

pubmed: 33046102
doi: 10.1186/s12969-020-00473-2
pii: 10.1186/s12969-020-00473-2
pmc: PMC7552512
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Références

J Pain. 2016 Dec;17(12):1334-1348
pubmed: 27641311
J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):693-4
pubmed: 18955880
Arthritis Rheum. 2002 Mar;46(3):714-25
pubmed: 11920407
Arch Dis Child. 2020 Oct;105(10):938-944
pubmed: 32152039
J Pediatr. 2015 Sep;167(3):731-7
pubmed: 26209526
J Pediatr. 2016 Feb;169:9-10
pubmed: 26681474
Clin J Pain. 2012 Nov-Dec;28(9):766-74
pubmed: 22688602
JAMA Pediatr. 2014 Dec;168(12):1167-8
pubmed: 25436848
J Pediatr. 2016 Feb;169:181-7.e1
pubmed: 26545727
Pain. 2010 Aug;150(2):268-74
pubmed: 20493633
Arthritis Rheum. 1985 Feb;28(2):138-45
pubmed: 3871615
Psychol Methods. 2002 Mar;7(1):19-40
pubmed: 11928888
J Pediatr Psychol. 1991 Feb;16(1):39-58
pubmed: 1826329
Best Pract Res Clin Rheumatol. 2011 Apr;25(2):133-9
pubmed: 22094190
Acad Pediatr. 2017 Sep - Oct;17(7S):S51-S69
pubmed: 28865661
J Rheumatol. 1992 Nov;19(11):1786-9
pubmed: 1491402
JAMA Pediatr. 2014 Dec;168(12):1167
pubmed: 25436847
JAMA Pediatr. 2014 Aug;168(8):693-4
pubmed: 24887181
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
Clin J Pain. 1999 Sep;15(3):218-23
pubmed: 10524475
Arch Dis Child. 1951 Apr;26(126):134-40
pubmed: 14830278
Curr Opin Rheumatol. 2014 Sep;26(5):592-603
pubmed: 25010441
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069

Auteurs

David D Sherry (DD)

Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, 3501 Civic Center Blvd, Philadelphia, PA, 19104-3820, USA. sherry@email.chop.edu.
University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA, USA. sherry@email.chop.edu.

Maitry Sonagra (M)

Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, 3501 Civic Center Blvd, Philadelphia, PA, 19104-3820, USA.
Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Roberts Center for Pediatric Research, Philadelphia, PA, 19146, USA.
Policy Lab, Children's Hospital of Philadelphia, Roberts Center for Pediatric Research, Philadelphia, PA, 19104, USA.

Sabrina Gmuca (S)

Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, 3501 Civic Center Blvd, Philadelphia, PA, 19104-3820, USA.
University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Roberts Center for Pediatric Research, Philadelphia, PA, 19146, USA.
Policy Lab, Children's Hospital of Philadelphia, Roberts Center for Pediatric Research, Philadelphia, PA, 19104, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH